Collingridge G. L., Singer W. 1990. Excitatory amino acid receptors and synaptic plasticity. Trends Pharmacol. Sci. 11, 290-296.
Collingridge G. L., Bliss T. V. P. 1995. Memories of NMDA receptors and LTP. Trends Neurosci. 18, 54-56.
Danysz W., Parsons C. G., Bresink I., Quack G. 1995. Glutamate in CNS disorders - A revived target for drug development. Drug News Perspect. 8, 261-277.
Obrenovitch T. P., Urenjak J. 1997. Altered glutamatergic transmission in neurological disorders: From high extracellular glutamate to excessive synaptic efficacy. Prog. Neurobiol. 51, 39-87.
Parsons C. G., Danysz W., Quack G. 1998. Glutamate in CNS Disorders as a target for drug development. An update. Drug News Perspect. 11, 523-569 .
Rothman S. M., Olney J. W. 1987. Excitotoxicity and the NMDA receptor. Trends Neurosci. 10, 299-302.
Choi D. W. 1995. Calcium: still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci. 18, 58-60.
Beal M. F. 1995. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann. Neurol. 38, 357-366.
Starr M. S. 1995. Antiparkinsonian actions of glutamate antagonists - alone and with l-DOPA: a review of evidence and suggestions for possible mechanisms. J. Neural Transm.- Parkinsons 10, 141-185.
Plaitakis A., Fesdjian C. O., Shashidharan P. 1996. Glutamate antagonists in amyotrophic lateral sclerosis: a review of their therapeutic potential. CNS Drugs 5, 437-456.
Shaw P. J., Ince P. G. 1997. Glutamate, excitotoxicity and amyotrophic lateral sclerosis. J. Neurol. 244, S3-S14.
Trujillo K. A., Akil H. 1995. Excitatory amino acids and drugs of abuse: a role for N-methyl-D-aspartate receptors in drug tolerance, sensitization and physical dependence. Drug Alcohol Depend. 38, 139-154.
Dickenson, A. 1997. Mechanisms of central hypersensitivity: Excitatory amino acid mechanisms and their control. In: Dickenson A., Besson J. M. (Eds), Pharmacology of Pain, Springer-Verlag Berlin, Heidelberger Platz 3/W-1000 Berlin 33/Germany, pp. 167-210.
Cancela J. M., Churchill G. C., Galione A. 1999. Coordination of agonist-induced Ca2+-signalling patterns by NAADP in pancreatic acinar cells. Nature 398, 74-6.
Hollmann M., Heinemann S. 1994. Cloned glutamate receptors. Annu. Rev. Neurosci. 17, 31-108.
Mcbain C. J., Mayer M. L. 1994. N-methyl-D-aspartic acid receptor structure and function. Physiol. Rev. 74, 723-760.
Danysz W., Parsons C. G. 1998. Glycine and N-methyl-D-aspartate receptors: Physiological significance and possible therapeutic applications. Pharmacol. Rev. 50, 597-664.
Rosenmund C., Stern Bach Y., Stevens C. F. 1998. The tetrameric structure of a glutamate receptor channel. Nature 280, 1596-1599.
Laube B., Kuhse J., Betz H. 1998. Evidence for a tetrameric structure of recombinant NMDA receptors. J. Neurosci. 18, 2954-2961.
Mansour M., Nagarajan N., Nehring R. B., Clements J. D., Rosenmund C. 2001. Heteromeric AMPA receptors assemble with a preferred subunit stoichiometry and spatial arrangement. Neuron 32, 841-53.
Sommer B., Keinanen K., Verdoorn T. A., Wisden W., Burnashev N., Herb A., Kohler M., Takagi T. 1990. Flip and Flop: a cell-specific functional switch in glutamate-operated channels of the CNS. Science 249, 1580-1584.
Monyer H., Seeburg P. H., Wisden W. 1991. Glutamate-operated channels - Developmentally early and mature forms arise by alternative splicing. Neuron 6, 799-810.
Schmitz D., Mellor J., Nicoll R. A. 2001. Presynaptic kainate receptor mediation of frequency facilitation at hippocampal mossy fiber synapses. Science 291, 1972-6.
Contractor A., Swanson G., Heinemann S. F. 2001. Kainate receptors are involved in short- and long-term plasticity at mossy fiber synapses in the hippocampus. Neuron 29, 209-16.
Abram S. E., Olson E. E. 1994. Systemic opioids do not suppress spinal sensitization after subcutaneous formalin in rats. Anesthesiology 80, 1114-9.
Lerma J., Morales M., Vicente M. A., Herreras O. 1997. Glutamate receptors of the kainate type and synaptic transmission. Trends Neurosci. 20, 9-12.
Vignes M., Bleakman D., Lodge D., Collingridge G. L. 1997. The synaptic activation of the GluR5 subtype of kainate receptor in area CA3 of the rat hippocampus. Neuropharmacology 36, 1477-1481.
Wilding T. J., Huettner J. E. 1997. Activation and desensitization of hippocampal kainate receptors. J. Neurosci. 17, 2713-2721.
Jones K. A., Wilding T. J., Huettner J. E., Costa A. M. 1997. Desensitization of kainate receptors by kainate, glutamate and diastereomers of 4-methylglutamate. Neuropharmacology 36, 853-863.
Partin K. M., Patneau D. K., Winters C. A., Mayer M. L., Buonanno A. 1993. Selective modulation of desensitization at AMPA versus kainate receptors by cyclothiazide and concanavalin-A. Neuron 11, 1069-1082.
Bleakman D., Ballyk B. A., Schoepp D. D., Palmer A. J., Bath C. P., Sharpe E. F., Woolley M. L., Bufton H. R., Kamboj R. K., Tarnawa I., Lodge D. 1996. Activity of 2,3-benzodiazepines at native rat and recombinant human glutamate receptors in vitro: Stereospecificity and selectivity profiles. Neuropharmacology 35, 1689-1702.
Rammes G., Swandulla D., Collingridge G. L., Hartmann S., Parsons C. G. 1996. Interactions of 2,3-benzodiazepines and cyclothiazide at AMPA receptors: patch clamp recordings in cultured neurones and area CA1 in hippocampal slices. Br. J. Pharmacol. 117, 1209-1221.
Rammes G., Swandulla D., Spielmanns P., Parsons C. G. 1998. Interactions of GYKI 52466 and NBQX with cyclothiazide at AMPA receptors: experiments with outside-out patches and EPSCs in hippocampal neurones. Neuropharmacology 37, 1299-1320.
Mosbacher J., Schoepfer R., Monyer H., Burnashev N., Seeburg P. H., Ruppersberg J. P. 1994. A molecular determinant for submillisecond desensitization in glutamate receptors. Science 266, 1059-1062.
Partin K. M., Fleck M. W., Mayer M. L. 1996. AMPA receptor flip/flop mutants affecting deactivation, desensitization, and modulation by cyclothiazide, aniracetam, and thiocyanate. J. Neurosci. 16, 6634-6647.
Burnashev N. 1996. Calcium permeability of glutamate-gated channels in the central nervous system. Current Opinion in Neurobiology 6, 311-317.
Verdoorn T. A., Burnashev N., Monyer H., Seeburg P. H., Sakmann B. 1991. Structural determinants of ion flow through recombinant glutamate receptor channels. Science 252, 1715-1718.
Bowie D., Mayer M. L. 1995. Inward rectification of both AMPA and kainate subtype glutamate receptors generated by polyamine-mediated ion channel block. Neuron 15, 453-462 .
Brackley P. T. H., Bell D. R., Choi S. K., Nakanishi K., Usherwood P. N. R. 1993. Selective antagonism of native and cloned kainate and NMDA receptors by polyamine-containing toxins. J. Pharmacol. Exp. Ther. 266 , 1573-1580.
Herlitze S., Raditsch M., Ruppersberg J. P., Jahn W., Monyer H., Schoepfer R., Witzemann V. 1993. Argiotoxin detects molecular differences in AMPA receptor channels. Neuron 10, 1131-1140.
Pellegrini-Giampietro D. E., Bennett M. V. L., Zukin R. S. 1992. Are Ca-2+-Permeable Kainate/Ampa Receptors More Abundant in Immature Brain. Neurosci. Lett. 144, 65-69.
Goldberg Y. P., Kalchman M. A., Metzler M., Nasir J., Zeisler J., Graham R., Koide H. B., O'Kusky J., Sharp A. H., Ross C. A., Jirik F., Hayden M. R. 1996. Absence of disease phenotype and intergenerational stability of the CAG repeat in transgenic mice expressing the human Huntington disease transcript. Hum Mol Genet 5, 177-85.
Racca C., Catania M. V., Monyer H., Sakmann B. 1996. Expression of AMPA-glutamate receptor b subunit in rat hippocampal GABAergic neurons. Eur. J. Neurosci. 8, 1580-1590.
Iino M., Goto K., Kakegawa W., Okado H., Sudo M., Ishiuchi S., Miwa A., Takayasu Y., Saito I., Tsuzuki K., Ozawa S. 2001. Glia-synapse interaction through Ca2+-permeable AMPA receptors in Bergmann glia. Science 292, 926-9.
Bear M. F., Malenka R. C. 1994. Synaptic plasticity: LTP and LTD. Curr. Opin. Neurobiol. 4, 389-399.
Danysz, W. and Parsons, C. G. 95. NMDA receptor antagonists - multiple modes of action on learning processes. Behav. Pharmacol. 6, 619.
Supplisson S., Bergman C. 1997. Control of NMDA receptor activation by a glycine transporter co-expressed in Xenopus oocytes. J. Neurosci. 17, 4580-4590.
Johnson T. D. 1996. Modulation of channel function by polyamines. Trends Pharmacol. Sci. 17, 22-7.
Williams K. 1997. Modulation and block of ion channels: A new biology of polyamines. Cellular Signalling 9, 1-13.
Zhang X. X., Shi W. X. 2001. Dynamic modulation of NMDA-induced responses by ifenprodil in rat prefrontal cortex. Synapse 39, 313-8.
Hirai H., Kirsch J., Laube B., Betz H., Kuhse J. 1996. The glycine binding site of the N-methyl-D-aspartate receptor subunit NR1: identification of novel determinants of co-agonist potentiation in the extracellular m3-m4 loop region. Proc. Natl. Acad. Sci. USA 93, 6031-6036.
Laube B., Hirai H., Sturgess M., Betz H., Kuhse J. 1997. Molecular determinants of agonist discrimination by NMDA receptor subunits: Analysis of the glutamate binding site on the NR2B subunit. Neuron 18, 493-503.
Zukin R. S., Bennett M. V. L. 1995. Alternatively spliced isoforms of the NMDARI receptor subunit. Trends Neurosci. 18, 306-313.
Laurie D. J., Putzke J., Zieglgansberger W., Seeburg P. H., Tolle T. R. 1995. The distribution of splice variants of the NMDAR1 subunit mRNA in adult rat brain. Mol. Brain Res. 32, 94-108.
Sucher N. J., Awobuluyi M., Choi Y. B., Lipton S. A. 1996. NMDA receptors: from genes to channels. Trends Pharmacol. Sci. 17, 348-355.
Tolle T. R., Berthele A., Zieglgansberger W., Seeburg P. H., Wisden W. 1993. The differential expression of 16 NMDA and non-NMDA receptor subunits in the rat spinal cord and in periaqueductal gray. J. Neurosci. 13, 5009-5028.
Sundstrom E., Whittemore S., Mo L. L., Seiger A. 1997. Analysis of NMDA receptors in the human spinal cord. Exp. Neurol. 148, 407-413.
Sucher N. J., Akbarian S., Chi C. L., Leclerc C. L., Awobuluyi M., Deitcher D. L., Wu M. K., Yuan J. P., Jones E. G., Lipton S. A. 1995. Developmental and regional expression pattern of a novel NMDA receptor-like subunit (NMDAR-l) in the rodent brain. J. Neurosci. 15, 6509-6520.
Matsuda K., Kamiya Y., Matsuda S., Yuzaki M. 2002. Cloning and characterization of a novel NMDA receptor subunit NR3B: a dominant subunit that reduces calcium permeability. Brain Res Mol Brain Res 100, 43-52.
Kinsley C. H., Madonia L., Gifford G. W., Tureski K., Griffin G. R., Lowry C., Williams J., Collins J., McLearie H., Lambert K. G. 1999. Motherhood improves learning and memory. Nature 402, 137-8.
Chatterton J. E., Awobuluyi M., Premkumar L. S., Takahashi H., Talantova M., Shin Y., Cui J., Tu S., Sevarino K. A., Nakanishi N., Tong G., Lipton S. A., Zhang D. 2002. Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits. Nature 415, 793-8.
Parsons C. G., Danysz W., Quack G. 1999. Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist - a review of preclinical data. Neuropharmacology 38, 735-767.
Jones M. W., McClean M., Parsons C. G., Headley P. M. 2001. The in vivo significance of the varied channel blocking properties of uncompetitive NMDA receptor antagonists. Neuropharmacology 41, 50-61.
Hargreaves R. J., Rigby M., Smith D., Hill R. G. 1993. Lack of effect of l-687,414 ((+)-cis-4-methyl-HA-966), an NMDA receptor antagonist acting at the glycine site, on cerebral glucose metabolism and cortical neuronal morphology. Br. J. Pharmacol. 110, 36-42.
Murata S., Kawasaki K. 1993. Common and uncommon behavioural effects of antagonists for different modulatory sites in the NMDA receptor/channel complex. Eur. J. Pharmacol. 239, 9-15.
Baron B. M., Harrison B. L., Kehne J. H., Schmidt C. J., VanGiersbergen P. L. M., White H. S., Siegel B. W., Senyah Y., McCloskey T. C., Fadayel G. M., Taylor V. L., Murawsky M. K., Nyce P., Salituro F. G. 1997. Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonist. Eur. J. Pharmacol. 323, 181-192.
Kretschmer B. D., Kratzer U., Breithecker K., Koch M. 1997. ACEA 1021, a glycine site antagonist with minor psychotomimetic and amnestic effects in rats. Eur. J. Pharmacol. 331, 109-116.
Bristow L. J., Flatman K. L., Hutson P. H., Kulagowski J. J., Leeson P. D., Young L., Tricklebank M. D. 1996. The atypical neuroleptic profile of the glycine/n-methyl-d-aspartate receptor antagonist, l-701,324, in rodents. J. Pharmacol. Exp. Ther. 277, 578-585.
Parsons C. G., Zong X. G., Lux H. D. 1993. Whole cell and single channel analysis of the kinetics of glycine-sensitive N-methyl-D-aspartate receptor desensitization. Br. J. Pharmacol. 109, 213-221.
Stone T. W. 2001. Kynurenines in the CNS: from endogenous obscurity to therapeutic importance. Prog. Neurobiol. 64, 185-218.
Hilmas C., Pereira E. F., Alkondon M., Rassoulpour A., Schwarcz R., Albuquerque E. X. 2001. The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. J. Neurosci. 21, 7463-73.
Karcz-Kubicha M., Jessa M., Nazar M., Plaznik A., Hartmann S., Parsons C. G., Danysz W. 1997. Anxiolytic activity of glycine-B antagonists and partial agonists - No relation to intrinsic activity in the patch clamp. Neuropharmacology 36, 1355-1367.
Henderson G., Johnson J. W., Ascher P. 1990. Competitive antagonists and partial agonists at the glycine modulatory site of the mouse N-methyl-D-aspartate receptor. J. Physiol. -London 430, 189-212.
Kemp J. A., Priestley T. 1991. Effects of (+)-HA-966 and 7-chlorokynurenic acid on the kinetics of N-methyl-D-asparatate receptor agonist responses in rat cultured cortical neurons. Mol. Pharmacol. 39, 666-670.
Witkin J. M., Steele T. D., Sharpe L. G. 1997. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline. J. Pharmacol. Exp. Ther. 280, 46-52.
Lanthorn T. H. 1994. D-cycloserine: agonist turned antagonist. Amino Acids 6, 247-260.
Fossom L. H., Basile A. S., Skolnick P. 1995. Sustained exposure to 1-aminocyclopropanecarboxylic acid, a glycine partial agonist, alters N-methyl-D-aspartate receptor function and subunit composition. Mol. Pharmacol. 48, 981-987.
Priestley T., Kemp J. A. 1994. Kinetic study of the interactions between the glutamate and glycine recognition sites on the N-methyl-D-aspartic acid receptor complex. Mol. Pharmacol. 46, 1191-1196.
Krueger, J. M., O'Connor, A. J., and Kelso, S. R. 97. Glycine site agonists exhibit subunit specific effects on NMDA receptors expressed in Xenopus oocytes. Soc. Neurosci. Abst. 23, 945.
O'Connor, A. J., Evalchogiannnis, G., and Moskal, J. 96. Subunit specific effects of D-cycloserine on NMDA receptor receptors expressed in Xenopus oocytes. Soc. Neurosci. Abs. 22, #604.15.
Sheinin A., Shavit S., Benveniste M. 2001. Subunit specificity and mechanism of action of NMDA partial agonist D- cycloserine. Neuropharmacology 41, 151-8.
Skolnick P., Marvizon J. C. G., Jackson B. W., Monn J. A., Pice K. C., Lewin A. P. 1989. Blockade of N-methyl-D-aspartate induced convulsions by 1-aminocyclopropanecarboxylates. Life Sci. 45, 1647-1656.
Skolnick P., Miller R., Young A., Boje K., Trullas R. 1992. Chronic treatment with 1-aminocyclopropanecarboxylic acid desensitizes behavioral responses to compounds acting at the N-methyl-D-aspartate receptor complex. Psychopharmacology 107, 489-496.
Papp M., Moryl E. 1996. Antidepressant-like effects of 1-aminocyclopropanecarboxylic acid and d-cycloserine in an animal model of depression. Eur. J. Pharmacol. 316, 145-151.
Legendre P., Westbrook G. L. 1991. Ifenprodil Blocks N-Methyl-D-Aspartate Receptors by a Two-Component Mechanism. Mol. Pharmacol. 40, 289-298.
Menniti F., Chenard B., Collins M., Ducat M., Shalaby I., White F. 1997. CP-101,606, a potent neuroprotectant selective for forebrain neurons. Eur. J. Pharmacol. 331, 117-126.
Chenard B. L., Menniti F. S. 1999. Antagonists selective for NMDA receptors containing the NR2B subunit. Current Pharmaceutical Design 5, 381-404.
Butler, T. W., Chenard, B. L., Collins, M. A., Ducat, M. F., Menniti, F. S., Pagnozzi, M. J., and White, W. F. 97. CP-283,097, a conformationally restricted analog of CP-101-606: structure activity relations . Soc. Neurosci. Abs. 23, #367.2.
Gill R., Kemp J. A., Richards J. G., Kew J. N. C. 1999. NMDA receptor antagonists: past disappointments and future prospects as neuroprotective agents. Current Opinion in Cardiovascular, Pulmonary & Renal Investigational Drugs 1, 576-591.
Gasparini F., Kuhn R., Pin J. P. 2002. Allosteric modulators of group I metabotropic glutamate receptors: novel subtype-selective ligands and therapeutic perspectives. Curr Opin Pharmacol 2, 43-9.
Wang Y., Small D. L., Stanimirovic D. B., Morley P., Durkin J. P. 1997. AMPA receptor-mediated regulation of a Gi-protein in cortical neurons. Nature 389, 502-4.
Kawai F., Sterling P. 1999. AMPA receptor activates a G-protein that suppresses a cGMP-gated current. J. Neurosci. 19, 2954-9.
Melyan Z., Wheal H. V., Lancaster B. 2002. Metabotropic-mediated kainate receptor regulation of IsAHP and excitability in pyramidal cells. Neuron 34, 107-14.
Vissel B., Krupp J. J., Heinemann S. F., Westbrook G. L. 2001. A use-dependent tyrosine dephosphorylation of NMDA receptors is independent of ion flux. Nat Neurosci 4, 587-596.
Oliet S. H., Piet R., Poulain D. A. 2001. Control of glutamate clearance and synaptic efficacy by glial coverage of neurons. Science 292, 923-6.
Arriza J. L., Fairman W. A., Wadiche J. I., Murdoch G. H., Kavanaugh M. P., Amara S. G. 1994. Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. J. Neurosci. 14, 5559-5569.
Malandro M. S., Kilberg M. S. 1996. Molecular biology of mammalian amino acid transporters. Annu. Rev. Biochem. 65, 305-336.
Blakely R. D., Robinson M. B., Guarda A. S., Coyle J. T. 1988. A re-examination of the interaction of N-acetyl-L-aspartyl-L-glutamate with a subpopulation of rat brain membrane L-[3H]glutamate binding sites . Eur. J. Pharmacol. 151, 419-426.
Neale J. H., Bzdega T., Wroblewska B. 2000. N-acetylaspartylglutamate: The most abundant peptide neurotransmitter in the mammalian central nervous system. J. Neurochem. 75, 443-452.
Jackson P. F., Slusher B. S. 2001. Design of naaladase inhibitors: a novel neuroprotective strategy. Curr Med Chem 8, 949-57.
Jeffery K. J. 1997. LTP and spatial learning - Where to next? Hippocampus 7, 95-110.
Baudry M. 1996. Similarities and contrasts between cerebellar LTD and hippocampal LTP. Behav. Brain Sci. 19, 435.
Rison R. A., Stanton P. K. 1995. Long-term potentiation and n-methyl-d-aspartate receptors: foundations of memory and neurologic disease? Neurosci. Biobehav. Rev. 19, 533-552.
Malenka R. C. 1994. Synaptic plasticity in the hippocampus: LTP and LTD. Cell 78, 535-538 .
Edwards F. A. 1995. LTP - a structural model to explain the inconsistencies. Trends Neurosci. 18, 250-255.
Herron C. E., Lester R. A. J., Coan E. J., Collingridge G. L. 1986. Frequency-dependent involvement of NMDA receptors in the hippocampus: a novel synaptic mechanism. Nature 322, 265-269.
Abraham W. C., Tate W. P. 1997. Metaplasticity: A new vista across the field of synaptic plasticity. Prog. Neurobiol. 52, 303-323.
Bayer K. U., De Koninck P., Leonard A. S., Hell J. W., Schulman H. 2001. Interaction with the NMDA receptor locks CaMKII in an active conformation. Nature 411, 801-5.
Lan J. Y., Skeberdis V. A., Jover T., Grooms S. Y., Lin Y., Araneda R. C., Zheng X., Bennett M. V., Zukin R. S. 2001. Protein kinase C modulates NMDA receptor trafficking and gating. Nat Neurosci 4, 382-90.
Pasinelli P., Ramakers G. M. J., Urban I. J. A., Hens J. J. H., Oestreicher A. B., De Graan P. N. E., Gispen W. H. 1995. Long-term potentiation and synaptic protein phosphorylation. Behav. Brain Res. 66, 53-59.
Lisman J. 1994. The cam kinase II hypothesis for the storage of synaptic memory. Trends Neurosci. 17, 406-412.
Benowitz L. I., Routtenberg A. 1997. GAP-43: An intrinsic determinant of neuronal development and plasticity. Trends Neurosci. 20, 84-91.
Grant S. G. N., Silva A. J. 1994. Targeting learning. Trends Neurosci. 17, 71-75.
Ambros-Ingerson J., Xiao P., Larson J., Lynch G. 1993. Waveform analysis suggests that LTP alters the kinetics of synaptic receptor channels. Brain Res. 620, 237-244.
Benke T. A., Luthi A., Isaac J. T. R., Collingridge G. L. 1998. Modulation of AMPA receptor unitary conductance by synaptic activity. Nature 393, 793-797.
Ambros-Ingerson J., Lynch G. 1993. Channel gating kinetics and synaptic efficacy - a hypothesis for expression of long-term potentiation. Proc. Natl. Acad. Sci. USA 90, 7903-7907.
Maren S., Tocco G., Standley S., Baudry M., Thompson R. F. 1993. Postsynaptic factors in the expression of long-term potentiation (LTP) - increased glutamate receptor binding following LTP induction invivo. Proc. Natl. Acad. Sci. USA 90, 9654-9658.
Kessler M., Arai A., Vanderliksh P., Lynch G. 1991. Failure to Detect Changes in AMPA Receptor Binding After Long-Term Potentiation. Brain Res. 560, 337-341.
Lynch M. A. 1989. Mechanisms underlying induction and maintenance of long-term potentiation in the hippocampus. Bioessays 10, 85-90.
Kato K., Uruno K., Saito K., Kato H. 1991. Both Arachidonic Acid and 1-Oleoyl-2-Acetyl Glycerol in Low Magnesium Solution Induce Long-Term Potentiation in Hippocampal CA1 Neurons Invitro. Brain Res. 563, 94-100.
Odell T. J., Hawkins R. D., Kandel E. R., Arancio O. 1991. Tests of the Roles of 2 Diffusible Substances in Long-Term Potentiation - Evidence for Nitric Oxide as a Possible Early Retrograde Messenger. Proc. Natl. Acad. Sci. USA 88, 11285-11289.
Schaechter J. D., Benowitz L. I. 1993. Activation of protein kinase-c by arachidonic acid selectively enhances the phosphorylation of GAP-43 in nerve terminal membranes. J. Neurosci. 13, 4361-4371.
Kato K., Clark G. D., Bazan N. G., Zorumski C. F. 1994. Platelet-activating factor as a potential retrograde messenger in CA1 hippocampal long-term potentiation. Nature 367, 175-179.
Luo Y., Vallano M. L. 1995. Arachidonic acid, but not sodium nitroprusside, stimulates presynaptic protein kinase C and phosphorylation of GAP-43 in rat hippocampal slices and synaptosomes. J. Neurochem. 64, 1808-1818.
Artola A., Hensch T., Singer W. 1996. Calcium-induced long-term depression in the visual cortex of the rat in vitro. J. Neurophysiol. 76, 984-994.
Artola A., Singer W. 1993. Long-term depression of excitatory synaptic transmission and its relationship to long-term potentiation. Trends Neurosci. 16, 480-487.
Christie B. R., Magee J. C., Johnston D. 1996. Dendritic calcium channels and hippocampal long-term depression. Hippocampus 6, 17-23.
Christie B. R., Kerr D. S., Abraham W. C. 1994. Flip side of synaptic plasticity: long-term depression mechanisms in the hippocampus. Hippocampus 4, 127-135.
Tsumoto T., Yasuda H. 1996. A switching role of postsynaptic calcium in the induction of long-term potentiation or long-term depression in visual cortex. Semin. Neurosci. 8, 311-319.
Tsumoto T., Yasuda H., Fukuda M., Akaneya Y. 1996. Postsynaptic calcium and calcium-dependent processes in synaptic plasticity in the developing visual cortex. J. Physiol. - Paris 90, 151-156.
Kirkwood A., Rioult M. G., Bear M. F. 1996. Experience-dependent modification of synaptic plasticity in visual cortex. Nature 381, 526-528.
Hansel C., Artola A., Singer W. 1996. Different threshold levels of postsynaptic [Ca2+](i) have to be reached to induce LTP and LTD in neocortical pyramidal cells. J. Physiol. - Paris 90, 317-319.
Derrick B. E., Martinez Jr J. L. 1996. Associative, bidirectional modifications at the hippocampal mossy fibre-CA3 synapse. Nature 381, 429-434.
Cummings J. A., Mulkey R. M., Nicoll R. A., Malenka R. C. 1996. Ca(2+) signaling requirements for long-term depression in the hippocampus. Neuron 16, 825-833.
Saucier D., Cain D. P. 1995. Spatial learning without NMDA receptor-dependent long-term potentiation. Nature 378, 186-189.
Bannerman D. M., Good M. A., Butcher S. P., Ramsay M., Morris R. G. M. 1995. Distinct components of spatial learning revealed by prior training and NMDA receptor blockade. Nature 378, 182-186.
Morris R. G. M. 1996. Further studies of the role of hippocampal synaptic plasticity in spatial learning: Is hippocampal LTP a mechanism for automatically recording attended experience? J. Physiol. - Paris 90 , 333-334.
Durand G. M., Kovalchuk Y., Konnerth A. 1996. Long-term potentiation and functional synapse induction in developing hippocampus. Nature 381, 71-75.
Isaac J. T. R., Oliet S. H. R., Hjelmstad G. O., Nicoll R. A., Malenka R. C. 1996. Expression mechanisms of long-term potentiation in the hippocampus. J. Physiol. - Paris 90, 299-303.
Isaac J. T. R., Hjelmstad G. O., Nicoll R. A., Malenka R. C. 1996. Long-term potentiation at single fiber inputs to hippocampal CA1 pyramidal cells. Proc. Natl. Acad. Sci. USA 93, 8710-8715.
Stricker C., Field A. C., Redman S. J. 1996. Statistical analysis of amplitude fluctuations in EPSCs evoked in rat CA1 pyramidal neurones in vitro. J. Physiol. 490, 419-441.
Stricker C., Field A. C., Redman S. J. 1996. Changes in quantal parameters of EPSCs in rat CA1 neurones in vitro after the induction of long-term potentiation. J. Physiol. 490, 443-454.
Rosenmund C., Clements J. D., Westbrook G. L. 1993. Nonuniform probability of glutamate release at a hippocampal synapse. Science 262, 754-757.
Manabe T., Nicoll R. A. 1994. Long-term potentiation: evidence against an increase in transmitter release probability in the CA1 region of the hippocampus. Science 265, 1888-1892.
Nicoll R. A., Malenka R. C. 1995. Contrasting properties of two forms of long-term potentiation in the hippocampus. Nature 377, 115-118.
Montgomery J. M., Madison D. V. 2002. State-dependent heterogeneity in synaptic depression between pyramidal cell pairs. Neuron 33, 765-77.
Liao D. Z., Hessler N. A., Malinow R. 1995. Activation of postsynaptically silent synapses during pairing-induced LTP in CA1 region of hippocampal slice. Nature 375, 400-404.
Montgomery J. M., Pavlidis P., Madison D. V. 2001. Pair recordings reveal all-silent synaptic connections and the postsynaptic expression of long-term potentiation. Neuron 29, 691-701.
Bibb J. A., Chen J., Taylor J. R., Svenningsson P., Nishi A., Snyder G. L., Yan Z., Sagawa Z. K., Ouimet C. C., Nairn A. C., Nestler E. J., Greengard P. 2001. Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature 410, 376-80.